• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconOpioid Crisis

Opioid Crisis

FinanceAll 50 states agree to OxyContin maker Purdue Pharma’s plan for Sackler family to pay up to $7 billion to settle opioid epidemic lawsuits
By Geoff Mulvihill and The Associated PressJune 18, 2025
FinancePurdue Pharma makes new offer to settle lawsuits over Oxycontin opioid crisis, and it includes up to $7 billion cash from the Sacklers
By Geoff Mulvihill and The Associated PressMarch 19, 2025
PoliticsChina says U.S. owes ‘big thank you’ on fentanyl, urges talks
By BloombergMarch 13, 2025
PoliticsCanada appoints former Mountie as fentanyl czar as part of deal with Trump to avoid 25% tariffs
By The Associated PressFebruary 12, 2025
Mexican flag waving
PoliticsHow do Mexico, Canada, and China affect fentanyl flowing into the U.S.?
By The Associated Press and Jesse BedaynFebruary 4, 2025
Close-up view of man in blue button-down shirt placing pills in his hand.
HealthNew pain drug, Vertex’s Journavx, gets FDA approval as safer alternative to addictive opioids
By Bloomberg and Gerry SmithJanuary 31, 2025
HealthPurdue Pharma and Sackler family to pay $7.4 billion in revised settlement of lawsuits over OxyContin opioid toll
By Geoff Mulvihill and The Associated PressJanuary 24, 2025
RetailKentucky reaches $110 million deal with Kroger to settle its opioid lawsuit—‘This massive grocery chain…allowed the fire of addiction to spread’
By The Associated PressJanuary 10, 2025
HealthOhio Supreme Court says counties can’t sue pharmacy chains in decision that could overturn a $650 million opioid judgment
By Julie Carr Smyth and The Associated PressDecember 11, 2024
A person stands outside of the Supreme Court holding a sign which reads "The Sacklers destroyed my parent's lives."
PoliticsThe Supreme Court just rejected a deal with the maker of OxyContin that would have shielded the billionaire Sackler family from liability—but provided billions of dollars to fight opioids
By The Associated Press and Mark ShermanJune 27, 2024
HealthArkansas is suing pharmacy benefit managers Express Scripts and Optum, accusing them of fueling the state’s opioid crisis
By Andrew DeMillo and The Associated PressJune 25, 2024
Gavin Newsom
PoliticsFrustrated by high drug prices, California will offer its own version of heavily discounted Narcan to stop fentanyl overdoses
By Adam Beam and The Associated PressApril 29, 2024
HealthOxyContin marketer and opioid maker announce $500m in settlements to avoid trials on their responsibility for crisis
By Geoff Mulvihill and The Associated PressFebruary 2, 2024
HealthEBay will pay $59m settlement over pill presses sold on the site—the kind used to make counterfeit pills laced with fentanyl
By Lindsay Whitehurst and The Associated PressFebruary 1, 2024
Bob Ferguson
Health‘They knew what the harm was. They did it anyway’: Johnson & Johnson pays $149.5 million to Washington state over opioids
By Manuel Valdes, Hallie Golden and The Associated PressJanuary 24, 2024
1
  • 1
  • 2
  • 3
  • 4
  • 5
...7
Most Popular
Law
DOGE cancelled a $349,000 grant to replace a museum’s HVAC after ChatGPT flagged it as DEI, court documents showAn image of a popular article
By Fortune EditorsMarch 19, 2026
Economy
Social Security has 6 years left. The fix that sounds cruelest may be the smartestAn image of a popular article
By Fortune EditorsMarch 19, 2026
Economy
Jerome Powell says you're right to blame data centers for making your bills more expensive: 'probably pushing inflation up'An image of a popular article
By Fortune EditorsMarch 19, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.